The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
The U.S. Meals and Drug Administration has granted orphan drug designation to the investigational remedy MNV-201 for sufferers with myelodysplastic syndrome, a...
For sufferers with myelofibrosis who had anemia at prognosis and obtained erythropoiesis-stimulating brokers (ESAs) or danazol together with Jakafi (ruxolitinib), enhancements in...
When reflecting on the Japanese artwork of kintsugi, one can discover inspiration throughout a most cancers journey, as CURE columnist Chester Freeman...
